Press release
Immune-Mediated Inflammatory Diseases Market Exclusive Report with Detailed Study Analysis
According to the latest research by InsightAce Analytic, the Immune-Mediated Inflammatory Diseases Market is predicted to grow with a CAGR of 7.10% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2889
A group of linked illnesses with a shared inflammatory mechanism that induces inflammation but an unclear etiology are collectively referred to as immune-mediated inflammatory diseases (IMIDs). Disorders caused by an overactive or abnormal immune system are known as immune-mediated inflammatory diseases.
Numerous of these diseases have underlying causes that may be connected to bad lifestyle choices, unhealthy eating habits, and genetic predispositions. As these disorders become more common, there is a growing global market for immune-mediated inflammatory diseases. In addition, the increasing frequency of autoimmune disorders across the globe is thereby driving the global market for immune-mediated inflammatory diseases.
List of Prominent Players in the Immune-Mediated Inflammatory Diseases Market:
• Novartis AG
• Daiichi Sankyo Company, Limited
• Pfizer Inc.
• Abbvie Inc.
• Merck & Co Inc.
• Zydus Group
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceuticals Industries Ltd.
• Amgen Inc.
• Boehringer Ingelheim International GmbH.
• AstraZeneca
• Ampio Pharmaceuticals Inc.
• Eli Lilly
• Akorn Incorporated
Market Dynamics:
Drivers-
The market will rise as immune-mediated inflammatory diseases like psoriasis, Crohn's disease, and rheumatoid arthritis become more common. The immune-mediated inflammatory diseases market expansion is also driven by the growing use of innovative and targeted biologic treatments for the treatment of immune-mediated inflammatory disorders. Additionally, the will expand as a result of the growing number of clinics, drugstores, and internet pharmacies that provide treatments for immune-mediated inflammatory illnesses.
Enquiry Before Buying:
@ https://www.insightaceanalytic.com/buy-report/2889
Challenges:
Throughout the course of the projected period, the shortage of skilled workers unable to carry out the treatments could impede the expansion of the worldwide market for immune-mediated inflammatory diseases. Additionally, the unfavourable side effects of the treatment process impede the expansion of the industry. Autoimmune reactions can result from side effects such as skin rashes and certain immunosuppressive medications.
Regional Trends:
The North American immune-mediated inflammatory diseases market is anticipated to note a major market share in terms of revenue. The increasing incidence of autoimmune disorders, the need for innovative treatments, and the increased emphasis on targeted biologic therapy are all factors contributing to the immune-mediated inflammatory diseases market's expansion.
The growing number of innovative therapy approvals and the rising demand for immunosuppressants in North America are also anticipated to propel the market. Besides, the Asia Pacific region had a considerable share of the market. Increased awareness of available treatments, the growing prevalence of autoimmune illnesses, and technical breakthroughs in the treatment of immune-mediated inflammatory diseases are all contributing factors to the market's growth in this area.
Recent Developments:
• In July 2024, AbbVie announced that the European Commission has sanctioned SKYRIZI® (risankizumab) for the treatment of elderly individuals with moderately to severely active ulcerative colitis (UC) who have experienced an inadequate response to, lost response to, or exhibited intolerance to conventional or biologic therapies.
Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/2889
Segmentation of Immune-Mediated Inflammatory Diseases Market-
By Indication-
• Asthma,
• Chronic Obstructive Pulmonary Diseases (COPD)
• Inflammatory Bowel Disease (IBD)
• Systemic Lupus Erythematosus (SLE)
• Rheumatoid Arthritis (RA)
• Psoriasis
• Others
By Treatment Type-
• Traditional Drugs
• Biologic Therapies
• Novel Therapies
By Route of Administration-
• Oral
• Parenteral
• Others
By End-Users-
• Hospitals
• Specialty Clinics
• Others
By Distribution Channel-
• Hospital Pharmacy
• Retail Pharmacy
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get More Information :
https://www.insightaceanalytic.com/report/immune-mediated-inflammatory-diseases-market/2889
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immune-Mediated Inflammatory Diseases Market Exclusive Report with Detailed Study Analysis here
News-ID: 4171750 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Green Technology and Sustainability Market Exclusive Report on the Latest Revenu …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Green Technology and Sustainability Market"-, By Component (Solutions & Services), By Deployment (Cloud & On-Premise), By Enterprise Type (Large Enterprise and SMEs), By Implemented Technology (Internet of Things, AI & Analytics, Digital Twin, Cloud Computing, Blockchain), By Application (Air & Water Pollution Monitoring, Carbon Footprint Management, Crop Monitoring, Fire Detection, Forest Monitoring, Green Building, Soil Condition…
Electric Powertrain Market Report Latest Trends and Future Opportunities Analysi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Electric Powertrain Market"-, By Integration Type (Integrated & Non-integrated), Component (Motor, Battery, BMS, Controller, PDM, Inverter/Converter, On-Board Charger), Propulsion (BEV, PHEV), Vehicle Type (PC & LCV), and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031."
The Electric Powertrain Market is estimated to reach over USD 301.6 billion by 2031, exhibiting a CAGR of 17.1%…
One Step RT-qPCR Kits Market Current Scenario with Future Aspect Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " One Step RT-qPCR Kits Market - (By Reaction (25 Rxn one step RT-qPCR kits, 50 Rxn one step RT-qPCR kits, 100 Rxn one step RT-qPCR kits, 200 Rxn one step RT-qPCR kits, 400 Rxn one step RT-qPCR kits, 500 Rxn one step RT-qPCR kits, 1000 Rxn one step RT-qPCR kits, and above 1000 Rxn one-step…
Wellness Tourism Market Deep Research Report with Forecast to 2034
"Wellness Tourism Market" in terms of revenue was estimated to be worth $ 991.7 billion in 2024 and is poised to reach $ 2727.5 billion by 2034, growing at a CAGR of 10.8% from 2025 to 2034 according to a new report by InsightAce Analytic.
Request For Free Sample Page @
https://www.insightaceanalytic.com/request-sample/1603
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Wellness Tourism Market are:
• Growing Global Awareness of…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
